NRX Pharmaceuticals (NRXP) Cash & Equivalents (QoQ) (2018 - 2026)
NRX Pharmaceuticals (NRXP) Cash & Equivalents (QoQ) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | NRX Pharmaceuticals | 117.34 Mn | 110.64 Mn | 437,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -14.07% |
| Dec 31, 2025 | 8.53% |
| Sep 30, 2025 | 147.72% |
| Jun 30, 2025 | -47.27% |
| Mar 31, 2025 | 281.15% |
| Dec 31, 2024 | -9.81% |
| Sep 30, 2024 | -15.79% |
| Jun 30, 2024 | 44.05% |
| Mar 31, 2024 | -71.29% |
| Dec 31, 2023 | -48.38% |
| Sep 30, 2023 | -40.53% |
| Jun 30, 2023 | -9.31% |
| Mar 31, 2023 | -17.69% |
| Dec 31, 2022 | 9.89% |
| Sep 30, 2022 | -25.66% |
| Jun 30, 2022 | -38.94% |
| Mar 31, 2022 | 45.63% |
| Dec 31, 2021 | -29.01% |
| Sep 30, 2021 | 190.47% |
| Jun 30, 2021 | 0.87% |